ANTI-CD37 ANTIBODY-DRUG CONJUGATE
The present invention provides: an antibody that specifically binds to CD37-positive tumor cells such as B-cell malignant lymphoma; an antibody-drug conjugate that contains said antibody; a pharmaceutical composition that employs said antibody and that exhibits a therapeutic effect on a tumor; a tum...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides: an antibody that specifically binds to CD37-positive tumor cells such as B-cell malignant lymphoma; an antibody-drug conjugate that contains said antibody; a pharmaceutical composition that employs said antibody and that exhibits a therapeutic effect on a tumor; a tumor treatment method employing said pharmaceutical composition; a method for producing said antibody; a method for producing said antibody-drug conjugate; and so forth. Provided is an anti-CD37 antibody-drug conjugate in which a drug linker, which is represented by the formula below, and an antibody are bonded by means of a thioether bond (in the formula, A indicates the position at which the linker is bonded with the antibody). Specifically, provided are: a humanized anti-CD37 antibody that exhibits an internalization activity; and an antibody-drug conjugate that contains said antibody. |
---|